Nobel Prize Laureate in Physiology or Medicine, Australian virologist Peter Doherty admired the data on the effectiveness of the Russian Sputnik V vaccine. Writes about this TASS.
According to him, the effectiveness of the Russian vaccine looks very encouraging, and in the event of a mutation of the virus, changing the drug will not be difficult. “The effectiveness – over 90 percent – looks great, and Russia has a long history of developing good vaccines,” Doherty said, adding that the strategy of using two adenoviral vectors makes sense.
The virologist emphasized that the strategy of using two adenoviral vectors was also used in the creation of vaccines by the pharmacological companies Janssen and AstraZeneca.
Earlier, journalist Jacques Schuster in a column for the German newspaper Die Welt said that Russia was able to surprise Western countries with the creation of a vaccine against the Sputnik V coronavirus. The journalist stressed that the effectiveness of the vaccine, as well as agreements on its use abroad, have given Russia a prestige that will be used politically.
Sputnik V is the first registered Russian vaccine against coronavirus, it was created on the basis of another adenovirus in which the coronavirus gene is embedded. When it enters cells, it forms proteins in them – they cause immunity and promote the development of antibodies.
